What everyone needs to expect about recovery post-surgery

Slowly but surely we are seeing increasing recognition in the clinical community of the need to ensure that prostate cancer patients and their spouses/partners really understand the likely consequences of treatment. … READ MORE …

Neoadjuvant ADT prior to radical surgery in high-risk prostate cancer patients

A group of South Korean researchers have just reported data on the prevalence and outcomes of pT0 disease after neoadjuvant androgen deprivation therapy (ADT) and radical prostatectomy among men receiving first-line therapy for high-risk prostate cancer. … READ MORE …

The side effects of radical prostatectomy: a new review

A new review article by a Danish research team in the Journal of Sexual Medicine has (arguably) brought a degree of clarity to what the authors refer to as “neglected” side effects consequent to radical prostatectomy. Unfortunately the average urologist probably doesn’t read the Journal of Sexual Medicine on a regular basis. … READ MORE …

Should we debulk the primary tumor in some men with metastatic prostate cancer?

Back in the 1980s, it would never (well, probably nearly never) have crossed anyone’s mind to carry out any type of primary tumor-debulking treatment on any patient who was newly diagnosed with evident, metastatic prostate cancer. … READ MORE …

Long-term impact on workplace status after radical prostatectomy

A recent Norwegian study has concluded that pre-surgical counseling of men electing treatment for prostate cancer by radical prostatectomy needs to include advice about risk for the possibility of post-surgical issues that may affect work status and their working life 3 years after their surgery. … READ MORE …

Patient life expectancy and application of radical prostatectomy in Ontario, Canada

An interesting epidemiological study just published on line in the Journal of Urology suggests that urologic surgeons in Ontario, Canada, are rather good at at estimating which patients diagnosed with prostate cancer have a life expectancy of 10+ years, making them reasonable candidates for radical prostatectomy. … READ MORE …

Radical prostatectomy: how much do YOU have to lose?

In a newly published paper in the Journal of Urology, researchers at the University of California, San Francisco have used data from CaPSURE to examine the relationship between age at surgery and quality of life pre- and post-surgery (for up to 2 years post-surgery). … READ MORE …

The surgical learning curve and post-RALP outcomes over time

Two new and quite separate papers offer rather different perspectives on the value of robot-assisted laparoscopic prostatectomy (RALP) as a first-line treatment for the management of localized prostate cancer. … READ MORE …

Managing common side effects of radical prostatectomy

We have already mentioned the article on genomics and biomarkers in this month’s issue of AUA News, but there are two other articles in this issue of the publication that are likely to be of interest to at least some of our regular readers. … READ MORE …

RALP in treatment of high-risk prostate cancer: a systematic review

Researchers from City of Hope in Los Angeles have conducted an expert, systematic review of the published literature on the use of robot-assisted, laparoscopic radical prostatectomy (RALP) in the management of high-risk, localized prostate cancer. … READ MORE …

IMRT probably no better than 3D-CRT after radical prostatectomy

In another relatively unsurprising finding, a paper in JAMA Internal Medicine has suggested that– from a clinical point of view — there is little difference in the outcomes of men treated with older rather than newer forms of radiation therapy after first-line surgery for localized prostate cancer. … READ MORE …

Whole-gland cryotherapy vs. radical prostatectomy as first-line treatment for localized disease

Over the years there have been very few studies that have attempted to make any type of direct comparison between outcomes of patients treated with whole-gland cryotherapy and outcomes of patients treated with other standard forms of whole gland therapy for localized prostate cancer. … READ MORE …

Pelvic lymph node dissection and robot-assisted laparoscopic radical prostatectomy

With the introduction of robot-assisted laparoscopic radical prostatectomy (RALP) there came suggestions from some surgeons that this technique made pelvic lymph node dissection (PLND) more difficult. However, a new review by a respected international group of authors clearly disagrees with this suggestion. … READ MORE …

ORRP vs. RALP in a large cohort of high-risk patients with localized prostate cancer

A relatively large, retrospective, single-institution cohort study appears to show that oncologic outcomes after robot-assisted laparoscopic prostatectomy (RALP) are comparable to those achieved after open retropubic radical prostatectomy (ORRP) among high-risk patients when the operations are carried out by appropriately skilled and experienced surgeons. … READ MORE …

A 17 percent potency rate post-surgery in one Swedish study

According to another media release issued on Sunday by the European Association of Urology, only 17 percent of a large cohort of Swedish men with prostate cancer who were potent prior to surgery were still potent 18 months post-surgery (whether they had nerve-sparing or non-nerve-sparing surgery). … READ MORE …